Why the Tide in Biotech May Finally Be Turning and What iShares Biotechnology ETF (IBB) Signals

Why the Tide in Biotech May Finally Be Turning and What iShares Biotechnology ETF (IBB) Signals

Key PointsAcquired 77,000 shares, valued at $11.1 millionTransaction represents 8.7% of 13F reportable AUMPost-trade position: 77,000 shares valued at $11.1 millionIBB is now the fund’s 2nd-largest holding, accounting for 8.7% of AUMThese 10 stocks could mint the next wave of millionaires › @media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: Getty Images…